U.S. DOD/CDMRP: Peer Reviewed Medical Research Program (PRMRP) – COVID-19 (for Emerging Viral Diseases and Respiratory Health– Pre-proposals

Topics of interest: Arthritis • Burn Pit Exposure • Cardiomyopathy • Congenital Heart Disease • Diabetes • Dystonia • Eating Disorders • Emerging Viral Diseases • Endometriosis • Epidermolysis Bullosa • Familial Hypercholesterolemia • Fibrous Dysplasia • Focal Segmental Glomerulosclerosis • Food Allergies • Fragile X • Frontotemporal Degeneration • Hemorrhage Control • Hepatitis B • Hydrocephalus • Hypertension • Inflammatory Bowel Diseases • Malaria • Metals Toxicology • Mitochondrial Disease • Myalgic Encephalomyelitis/Chronic Fatigue Syndrome • Myotonic Dystrophy • Non-Opioid Therapy for Pain Management • Nutrition Optimization • Pathogen-Inactivated Blood Products • Peripheral Neuropathy • Plant-Based Vaccines • Platelet-Like Cell Production • Polycystic Kidney Disease • Pressure Ulcers • Pulmonary Fibrosis • Respiratory Health • Rheumatoid Arthritis • Sleep Disorders and Restriction • Suicide Prevention • Sustained Release Drug Delivery • Vascular Malformations • Women’s Heart Disease

*Clinical Trial Award- Funding limit not defined. Duration 4 years.

*Focused Program Award: Maximum of $7.2 million for 4 years.

https://ebrap.org/eBRAP/public/Program.htm